Praxis Precision Medicines (PRAX) Misses Q1 EPS by 42c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($3.29), $0.42 worse than the analyst estimate of ($2.87).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• UDynamics files for Nasdaq IPO of 5.6 million shares at $5-$7 per share
• MGE Energy (MGEE) Declares $0.5083 Quarterly Dividend; 2.6% Yield